Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction

Tran Duong Thuy, Nam Nhut Phan, Chih Yang Wang, Han Gang Yu, Shu Yin Wang, Pung Ling Huang, Yi Yin Do, Yen Chang Lin

研究成果: 雜誌貢獻文章同行評審

28 引文 斯高帕斯(Scopus)


Diabetes is a risk factor that increases the occurrence and severity of cardiovascular events. Cardiovascular complications are the leading cause of mortality of 75% of patients with diabetes >40 years old. Sesamin, the bioactive compound extracted from Sesamum indicum, is a natural compound that has diverse benefcial effects on hypoglycemia and reducing cholesterol. The aim of this study is to investigate sesamin effects to diabetes-inducing cardiac hypertrophy. In the present study bioinformatics analysis demonstrated cardiac hypertrophy signaling may be the most important pathway for upregulating genes in sesamin-treated groups. To verify the bioinformatics prediction, sesamin was used as the main bioactive compound to attenuate the impact of diabetes induced by streptozotocin (STZ) on cardiac function in a rat model. The results revealed that oral administration of sesamin for 4 weeks (100 and 200 mg/kg body weight) marginally improved blood glucose levels, body weight and signifcantly ameliorated the effects on heart rate and blood pressure in rats with type 1 diabetes relative to control rats. The QT interval of sesamin was also reduced relative to the control group. The fndings indicated that sesamin has potential cardioprotective effects in the STZ-induced diabetes model. This suggested that this can be used as a novel treatment for patients with diabetes with cardiac dysfunction complication.
頁(從 - 到)2949-2956
期刊Molecular Medicine Reports
出版狀態已發佈 - 1月 1 2017

ASJC Scopus subject areas

  • 生物化學
  • 分子醫學
  • 分子生物學
  • 遺傳學
  • 腫瘤科
  • 癌症研究


深入研究「Novel therapeutic effects of sesamin on diabetes-induced cardiac dysfunction」主題。共同形成了獨特的指紋。